An emerging generation of endocrine therapies in breast cancer: a clinical perspective

Complex II - Bioblast

Effect of lasofoxifene on the progression of primary tumors

CDK4/6i-treated HR+/HER2- breast cancer tumors show higher ESR1

Endocrine resistance

Cancer Research and Treatment

Moving Beyond Binary: Redefining HER2 Breast Cancer Classification and Treatment - Cancer Therapy Advisor

B cells in tumor metastasis: friend or foe?

6.7 Neoadjuvant Therapy

Breast cancer - Wikipedia

ZB716, a steroidal selective estrogen receptor degrader (SERD), is